title: Simultaneous Platelet P2Y12 and P2Y1 ADP Receptor Blockade: Are Two Better Than One?
authors.affiliation: From the Brigham and Women's Hospital Heart and Vascular Center, Department of Medicine, and Harvard Medical School, Boston, MA.
authors.forename: Muthiah
authors.initials: M
authors.lastname: Vaduganathan
authors.affiliation: From the Brigham and Women's Hospital Heart and Vascular Center, Department of Medicine, and Harvard Medical School, Boston, MA. dlbhattmd@post.harvard.edu.
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000187:drug effects*; D003328:Coronary Thrombosis / Q000188:drug therapy*; D015226:Dinucleoside Phosphates / Q000494:pharmacology*; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D058921:Purinergic P2Y Receptor Antagonists / Q000494:pharmacology*; D058472:Receptors, Purinergic P2Y1 / Q000187:drug effects*; D058925:Receptors, Purinergic P2Y12 / Q000187:drug effects*
chemical_list: D015226:Dinucleoside Phosphates; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D058472:Receptors, Purinergic P2Y1; D058925:Receptors, Purinergic P2Y12
keywords: Editorial; acute coronary syndrome; blood platelets; pharmacology; platelet aggregation inhibitors; thrombosis